{"title":"《美国医学会杂志》分析了ADHD药物与精神病之间的联系","authors":"Valerie A. Canady","doi":"10.1002/mhw.34583","DOIUrl":null,"url":null,"abstract":"<p>A new meta-analysis is raising fresh concerns about the psychiatric risks associated with stimulant treatment for attention-deficit/hyperactivity disorder (ADHD). Drawing on data from nearly 400,000 individuals across 16 studies, researchers found that the occurrence of psychosis and bipolar disorder (BD) in stimulant-treated patients was “nonnegligible.”</p>","PeriodicalId":100916,"journal":{"name":"Mental Health Weekly","volume":"35 35","pages":"3-4"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"JAMA analysis examines link between ADHD meds, psychosis\",\"authors\":\"Valerie A. Canady\",\"doi\":\"10.1002/mhw.34583\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A new meta-analysis is raising fresh concerns about the psychiatric risks associated with stimulant treatment for attention-deficit/hyperactivity disorder (ADHD). Drawing on data from nearly 400,000 individuals across 16 studies, researchers found that the occurrence of psychosis and bipolar disorder (BD) in stimulant-treated patients was “nonnegligible.”</p>\",\"PeriodicalId\":100916,\"journal\":{\"name\":\"Mental Health Weekly\",\"volume\":\"35 35\",\"pages\":\"3-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mental Health Weekly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/mhw.34583\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mental Health Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/mhw.34583","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
JAMA analysis examines link between ADHD meds, psychosis
A new meta-analysis is raising fresh concerns about the psychiatric risks associated with stimulant treatment for attention-deficit/hyperactivity disorder (ADHD). Drawing on data from nearly 400,000 individuals across 16 studies, researchers found that the occurrence of psychosis and bipolar disorder (BD) in stimulant-treated patients was “nonnegligible.”
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
